Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 7/2013

01-07-2013 | Original Article

Changes of T Cells and Cytokines TGF-β1 and IL-10 in Mice During Liver Metastasis of Colon Carcinoma: Implications for Liver Anti-tumor Immunity

Authors: Xiaoming Huang, Yifeng Zou, Lei Lian, Xiaojian Wu, Xiaosheng He, Xiaowen He, Xianrui Wu, Yan Huang, Ping Lan

Published in: Journal of Gastrointestinal Surgery | Issue 7/2013

Login to get access

Abstract

Background

The local and systemic regulation of the immune system may play important roles in the process of liver metastasis of colorectal carcinoma. The aim of this study was to establish a reproducible experimental liver metastasis model, to identify changes in T cells and cytokines TGF-β1 and IL-10, and to explore a possible mechanism of liver metastasis of colon carcinoma.

Methods

We used a colon carcinoma liver metastasis model, in which different numbers of CT-26 murine colon carcinoma cells (1 × 103, 5 × 103, 1 × 104, 5 × 104, and 1 × 105) were injected into the spleen. The liver and spleen tissues were examined for T cell markers using flow cytometry. Liver tissues were analyzed for IL-10 and transforming growth factor beta 1 (TGF-β1) expression using immunohistochemistry.

Results

Spleen injection of colon carcinoma cells is a reproducible animal model for liver metastases, which resulted in quantity-dependent metastatic growth. We provided a snapshot of the hepatic immune microenvironment in the mouse liver metastasis model. Injection of A large number of tumor cells (5 × 104 and 1 × 10 5 ) decreased anti-tumor cell counts, such as CD4+ and CD8+ T cells, and increased immune-suppressive cell counts (CD4+CD25+ Treg cells). In addition, the expression levels of immunosuppressive cytokines IL-10 and TGF-β1 were also increased with the number of tumor cells.

Conclusions

Changes in the systemic and local immunological environment contribute to immunological escape mechanisms during liver metastasis of colon carcinoma, and therapies aiming at immune microenvironment may prove a useful strategy in the treatment of metastatic disease in the future.
Literature
1.
go back to reference Watanabe T, Kobunai T, Yamamoto Y, et al. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur J Cancer, 2010; 46: 2119–26.PubMedCrossRef Watanabe T, Kobunai T, Yamamoto Y, et al. Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. Eur J Cancer, 2010; 46: 2119–26.PubMedCrossRef
2.
go back to reference Kim J C, Roh S A, Kim H C, Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. J Gastrointest Surgs, 2003; 7:931–380.CrossRef Kim J C, Roh S A, Kim H C, Coexpression of carcinoembryonic antigen and E-cadherin in colorectal adenocarcinoma with liver metastasis. J Gastrointest Surgs, 2003; 7:931–380.CrossRef
3.
go back to reference Anaya DA, Becker NS, Abraham NS. Global graying, colorectal cancer and liver metastasis: new implications for surgical management. Crit Rev Oncol Hematol, 2011; 77: 100–8.PubMedCrossRef Anaya DA, Becker NS, Abraham NS. Global graying, colorectal cancer and liver metastasis: new implications for surgical management. Crit Rev Oncol Hematol, 2011; 77: 100–8.PubMedCrossRef
4.
go back to reference de Jong GM, Aarts F, Hendriks T, et al. Animal models for liver metastases of colorectal cancer: research review of preclinical studies in rodents. J Surg Res, 2009; 154: 167–76.PubMedCrossRef de Jong GM, Aarts F, Hendriks T, et al. Animal models for liver metastases of colorectal cancer: research review of preclinical studies in rodents. J Surg Res, 2009; 154: 167–76.PubMedCrossRef
5.
go back to reference Nathan H, de Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg, 2010; 210:755–66.PubMedCrossRef Nathan H, de Jong MC, Pulitano C, et al. Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg, 2010; 210:755–66.PubMedCrossRef
6.
go back to reference Sasaki A, Iwashita Y, Shibata K, et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg, 2005; 9:374–380.PubMedCrossRef Sasaki A, Iwashita Y, Shibata K, et al. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma. J Gastrointest Surg, 2005; 9:374–380.PubMedCrossRef
7.
go back to reference Grimm M, Gasser M, Bueter M, et al. Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer, 2010; 10: 82.PubMedCrossRef Grimm M, Gasser M, Bueter M, et al. Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer, 2010; 10: 82.PubMedCrossRef
8.
go back to reference Kelly AM, Golden-Mason L, Traynor O, et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumor immunity. Cytokine, 2006; 35:171–9.PubMedCrossRef Kelly AM, Golden-Mason L, Traynor O, et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumor immunity. Cytokine, 2006; 35:171–9.PubMedCrossRef
9.
go back to reference Dunne J, Lynch S, O'Farrelly C, et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol, 2001; 167: 3129–38.PubMed Dunne J, Lynch S, O'Farrelly C, et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol, 2001; 167: 3129–38.PubMed
10.
go back to reference Lutsiak ME, Semnani RT, De Pascalis R, et al. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood, 2005; 105: 2862–8.PubMedCrossRef Lutsiak ME, Semnani RT, De Pascalis R, et al. Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood, 2005; 105: 2862–8.PubMedCrossRef
11.
go back to reference Bierie B, Moses HL. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine & Growth Factor Reviews, 2010; 21: 49–59.CrossRef Bierie B, Moses HL. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine & Growth Factor Reviews, 2010; 21: 49–59.CrossRef
12.
go back to reference Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003; 425: 577–84.PubMedCrossRef Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 2003; 425: 577–84.PubMedCrossRef
13.
go back to reference Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol, 2010; 31: 220–7.PubMedCrossRef Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol, 2010; 31: 220–7.PubMedCrossRef
14.
go back to reference Herbeuval JP, Lelievre E, Lambert C, et al. (2004) Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol, 172: 4630–6.PubMed Herbeuval JP, Lelievre E, Lambert C, et al. (2004) Recruitment of STAT3 for production of IL-10 by colon carcinoma cells induced by macrophage-derived IL-6. J Immunol, 172: 4630–6.PubMed
15.
go back to reference Liu HY, Huang ZL, Yang GH, et al. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. World J Gastroenterol, 2008. 14(48): p. 7386–91.PubMedCrossRef Liu HY, Huang ZL, Yang GH, et al. Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. World J Gastroenterol, 2008. 14(48): p. 7386–91.PubMedCrossRef
16.
go back to reference Kollmar O, Schilling MK, Menger MD. Experimental liver metastasis. Standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 2004; 5 :453–460.CrossRef Kollmar O, Schilling MK, Menger MD. Experimental liver metastasis. Standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 2004; 5 :453–460.CrossRef
17.
go back to reference Disis ML, Bernhard H, Jaffee EM. Use of tumor-responsive T cells as cancer treatment. Lancet, 2009; 373: 673–83.PubMedCrossRef Disis ML, Bernhard H, Jaffee EM. Use of tumor-responsive T cells as cancer treatment. Lancet, 2009; 373: 673–83.PubMedCrossRef
18.
go back to reference Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Current Opinion in Genetics & Development, 2008; 18:11–8.CrossRef Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Current Opinion in Genetics & Development, 2008; 18:11–8.CrossRef
19.
go back to reference de la Cruz-Merino, L, et al. Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms. Clin Dev Immunol, 2011. 2011: p. 174149.PubMed de la Cruz-Merino, L, et al. Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms. Clin Dev Immunol, 2011. 2011: p. 174149.PubMed
20.
go back to reference Folprecht G, Gruenberger T, Bechstein WO. Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol, 2010; 11: 38–47.PubMedCrossRef Folprecht G, Gruenberger T, Bechstein WO. Tumor response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol, 2010; 11: 38–47.PubMedCrossRef
21.
go back to reference Midgley R, Kerr D. Immunotherapy for colorectal cancer: a challenge to clinical trial design. Lancet Oncol, 2000; 1: 159–68.PubMedCrossRef Midgley R, Kerr D. Immunotherapy for colorectal cancer: a challenge to clinical trial design. Lancet Oncol, 2000; 1: 159–68.PubMedCrossRef
22.
go back to reference Almeida AR, et al. CD4(+)CD25(+) Treg regulate the contribution of CD8(+) T-cell subsets in repopulation of the lymphopenic environment. Eur J Immunol, 2010; 40:3478–88.PubMedCrossRef Almeida AR, et al. CD4(+)CD25(+) Treg regulate the contribution of CD8(+) T-cell subsets in repopulation of the lymphopenic environment. Eur J Immunol, 2010; 40:3478–88.PubMedCrossRef
23.
go back to reference Zanin-Zhorov A, Ding Y, Kumari S, et al. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science, 2010; 328:372–6.PubMedCrossRef Zanin-Zhorov A, Ding Y, Kumari S, et al. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science, 2010; 328:372–6.PubMedCrossRef
24.
go back to reference Bierie B, Moses HL. Tumor microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer, 2006; 6: 506–20.PubMedCrossRef Bierie B, Moses HL. Tumor microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer, 2006; 6: 506–20.PubMedCrossRef
25.
go back to reference Nagaraj NS, Datta PK. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs, 2010; 19: 77–91.PubMedCrossRef Nagaraj NS, Datta PK. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs, 2010; 19: 77–91.PubMedCrossRef
Metadata
Title
Changes of T Cells and Cytokines TGF-β1 and IL-10 in Mice During Liver Metastasis of Colon Carcinoma: Implications for Liver Anti-tumor Immunity
Authors
Xiaoming Huang
Yifeng Zou
Lei Lian
Xiaojian Wu
Xiaosheng He
Xiaowen He
Xianrui Wu
Yan Huang
Ping Lan
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 7/2013
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2194-5

Other articles of this Issue 7/2013

Journal of Gastrointestinal Surgery 7/2013 Go to the issue